Top Mid-Cap Biotech Companies Increased Revenues to $26.5 Billion in 2014, says GlobalData
Combined total revenues for peer group of 35 mid-cap biotech companies increased from $24.8 billion in 2013 to $26.5 billion in 2014
09-Apr-2015 -
The combined total revenues for the peer group of 35 mid-cap biotech companies increased from $24.8 billion in 2013 to $26.5 billion in 2014, representing a Compound Annual Growth Rate (CAGR) of 21.9%, according to research and consulting firm GlobalData.The company’s report "PharmaLeaders: ...
biotechnology
GlobalData
market researches